loadpatents
name:-0.045975208282471
name:-0.017842054367065
name:-0.01452898979187
SKWIERCZYNSKI; Raymond D. Patent Filings

SKWIERCZYNSKI; Raymond D.

Patent Applications and Registrations

Patent applications and USPTO patent grants for SKWIERCZYNSKI; Raymond D..The latest application filed is for "aqueous formulations of water insoluble cox-2 inhibitors".

Company Profile
13.16.34
  • SKWIERCZYNSKI; Raymond D. - Andover MA
  • Skwierczynski; Raymond D. - Cambridge MA
  • Skwierczynski; Raymond D. - Saint Paul MN US
  • Skwierczynski; Raymond D. - Oakdale MN
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Aqueous Formulations Of Water Insoluble Cox-2 Inhibitors
App 20220125773 - SIPPY; Bradford C. ;   et al.
2022-04-28
Novel Dosage Forms Of Rofecoxib And Related Methods
App 20220047542 - Sippy; Bradford C. ;   et al.
2022-02-17
Boronate Ester Compounds And Pharmaceutical Compositions Thereof
App 20220009948 - Elliott; Eric L. ;   et al.
2022-01-13
Purified Forms Of Rofecoxib, Methods Of Manufacture And Use
App 20210236455 - Skwierczynski; Raymond D. ;   et al.
2021-08-05
Compositions and methods related to pyridinoylpiperidine 5-HT.sub.1F agonists
Grant 11,053,214 - Allieri , et al. July 6, 2
2021-07-06
Boronate Ester Compounds And Pharmaceutical Compositions Thereof
App 20210198289 - Elliott; Eric L. ;   et al.
2021-07-01
Novel Dosage Forms Of Rofecoxib And Related Methods
App 20210169845 - Sippy; Bradford C. ;   et al.
2021-06-10
Novel Dosage Forms Of Rofecoxib And Related Methods
App 20210137878 - Sippy; Bradford C. ;   et al.
2021-05-13
Purified forms of rofecoxib, methods of manufacture and use
Grant 10,987,337 - Skwierczynski , et al. April 27, 2
2021-04-27
Dosage forms of rofecoxib and related methods
Grant 10,945,992 - Sippy , et al. March 16, 2
2021-03-16
Boronate Ester Compounds And Pharmaceutical Compositions Thereof
App 20200392164 - Elliott; Eric L. ;   et al.
2020-12-17
Boronate Ester Compounds And Pharmaceutical Compositions Thereof
App 20200247829 - Kind Code
2020-08-06
Boronate Ester Compounds And Pharmaceutical Compositions Thereof
App 20200181176 - Elliott; Eric L. ;   et al.
2020-06-11
Boronate ester compounds and pharmaceutical compositions thereof
Grant 10,604,538 - Elliott , et al.
2020-03-31
Compositions And Methods Related To Pyridinoylpiperdine 5-ht1f Agonists
App 20200087279 - Allieri; Brigida ;   et al.
2020-03-19
Boronate ester compounds and pharmaceutical compositions thereof
Grant 10,526,351 - Elliott , et al. J
2020-01-07
Boronate Ester Compounds And Pharmaceutical Compositions Thereof
App 20200002361 - Elliott; Eric L. ;   et al.
2020-01-02
Boronate Ester Compounds And Pharmaceutical Compositions Thereof
App 20190263839 - Elliott; Eric L. ;   et al.
2019-08-29
Boronate Ester Compounds And Pharmaceutical Compositions Thereof
App 20190152997 - Elliott; Eric L. ;   et al.
2019-05-23
Boronate Ester Compounds And Pharmaceutical Compositions Thereof
App 20190048028 - Elliott; Eric L. ;   et al.
2019-02-14
Aqueous gel formulations containing immune response modifiers
Grant 10,071,156 - Ma , et al. September 11, 2
2018-09-11
Boronate Ester Compounds And Pharmaceutical Compositions Thereof
App 20180208609 - Elliott; Eric L. ;   et al.
2018-07-26
Boronate Ester Compounds And Pharmaceutical Compositions Thereof
App 20180002350 - Elliott; Eric L. ;   et al.
2018-01-04
Pharmaceutical compositions for the treatment of cancer and other diseases or disorders
Grant 9,504,693 - Ramanan , et al. November 29, 2
2016-11-29
Pharmaceutical Compositions For The Treatment Of Cancer And Other Diseases Or Disorders
App 20160158244 - Ramanan; Vijayalakshmi ;   et al.
2016-06-09
Aqueous Gel Formulations Containing Immune Response Modifiers
App 20160101173 - MA; DAVID Q. ;   et al.
2016-04-14
Boronate Ester Compounds And Pharmaceutical Compositions Thereof
App 20160031913 - Elliott; Eric L. ;   et al.
2016-02-04
Aqueous gel formulations containing immune response modifiers
Grant 9,248,127 - Perman , et al. February 2, 2
2016-02-02
Boronate ester compounds and pharmaceutical compositions thereof
Grant 9,175,018 - Elliott , et al. November 3, 2
2015-11-03
Boronate ester compounds and pharmaceutical compositions thereof
Grant 9,175,017 - Elliott , et al. November 3, 2
2015-11-03
Boronate Ester Compounds And Pharmaceutical Compositions Thereof
App 20150307523 - Elliott; Eric L. ;   et al.
2015-10-29
Pharmaceutical compositions for the treatment of cancer and other diseases or disorders
Grant 9,127,011 - Ramanan , et al. September 8, 2
2015-09-08
Boronate Ester Compounds And Pharmaceutical Compositions Thereof
App 20140349966 - Elliott; Eric L. ;   et al.
2014-11-27
Boronate Ester Compounds And Pharmaceutical Compositions Thereof
App 20140343314 - Elliott; Eric L ;   et al.
2014-11-20
Boronate ester compounds and pharmaceutical compositions thereof
Grant 8,859,504 - Elliott , et al. October 14, 2
2014-10-14
Pharmaceutical Compositions For The Treatment Of Cancer And Other Diseases Or Disorders
App 20140073630 - Ramanan; Vijayalakshmi ;   et al.
2014-03-13
Boronate Ester Compounds And Pharmaceutical Compositions Thereof
App 20140018301 - Elliott; Eric L. ;   et al.
2014-01-16
Boronate Ester Compounds And Pharmaceutical Compositions Thereof
App 20130165390 - Elliott; Eric L. ;   et al.
2013-06-27
Pharmaceutical formulations comprising an immune response modifier
Grant 7,968,562 - Skwierczynski , et al. June 28, 2
2011-06-28
Pharmaceutical Compositions For The Treatment Of Cancer And Other Diseases Or Disorders
App 20110039826 - Ramanan; Vijayalakshmi ;   et al.
2011-02-17
Boronate Ester Compounds And Pharmaceutical Compositions Thereof
App 20090325903 - Elliott; Eric L. ;   et al.
2009-12-31
Aqueous Gel Formulations Containing Immune Response Modifiers
App 20090163532 - Perman; Christopher S. ;   et al.
2009-06-25
Polymorphs of 1-(2-Methylpropyl)-1H-Imidazo[4,5-C][1,5]Naphthyridin-4-Amine Ethane-Sulfonate
App 20090124652 - Ach; David ;   et al.
2009-05-14
Pharmaceutical Formulations Comprising An Immune Response Modifier
App 20080275077 - Skwierczynski; Raymond D. ;   et al.
2008-11-06
Aqueous Gel Formulations Containing 1-(2-Methylpropyl)-1H-Imidazo[4,5-C][1,5]Naphthyridin-4-Amine
App 20080207675 - Ma; David Q. ;   et al.
2008-08-28
1-(2-Methylpropyl)-1H-Imidazo[4,5-C](1,5]Naphthyridin-4-Amine Ethanesulfonate and 1-(2-Methylpropyl)-1H-Imidazo[4,5-C](1,5]Naphthyridin-4-Amine Methanesulfonate
App 20080188513 - Skwierczynski; Raymond D. ;   et al.
2008-08-07
Pharmaceutical formulation comprising an immune response modifier
App 20030199538 - Skwierczynski, Raymond D. ;   et al.
2003-10-23
Formulations and methods for treatment of mucosal associated conditions with an immune response modifier
Grant 6,486,168 - Skwierczynski , et al. November 26, 2
2002-11-26
Formulations and methods for treatment of mucosal associated conditions with an immune response modifier
Grant 6,245,776 - Skwierczynski , et al. June 12, 2
2001-06-12

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed